Home › Funds › Royce & Associates › CRMD
Royce & Associates position in CRMD
CORMEDIX INC · Health Care
Latest position (Q2 2026)2.18M sh
Reported value held$17.08M
Portfolio Weight0.14%
First reportedQ3 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 441.31K | $5.13M | New |
| Q4 2025 | 242.02K | $2.81M | Reduce |
| Q1 2026 | 1.89M | $12.82M | Add |
| Q2 2026 | 2.18M | $17.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CRMD
- Vanguard Group 4.50M sh · $52.32M · Q4 2025
- BlackRock Inc 6.32M sh · $49.64M · Q2 2026
- Geode Capital Management 1.95M sh · $15.29M · Q2 2026
- UBS Group AG 1.88M sh · $14.74M · Q2 2026
- Marshall Wace 779.53K sh · $6.12M · Q2 2026
- Northern Trust Corp 756.43K sh · $5.94M · Q2 2026
- Charles Schwab Investment Management 618.17K sh · $4.85M · Q2 2026
- Goldman Sachs Group 466.39K sh · $3.66M · Q2 2026
- Morgan Stanley 423.34K sh · $3.32M · Q2 2026
- BNY Mellon 395.91K sh · $3.11M · Q2 2026
- Wellington Management Group 215.79K sh · $1.69M · Q2 2026